Literature DB >> 28566328

Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer.

Emmanuel Rios Velazquez1, Chintan Parmar1, Ying Liu2,3, Thibaud P Coroller1, Gisele Cruz4, Olya Stringfield2, Zhaoxiang Ye3, Mike Makrigiorgos1, Fiona Fennessy4, Raymond H Mak1, Robert Gillies2, John Quackenbush5,6,7, Hugo J W L Aerts8,4,5.   

Abstract

Tumors are characterized by somatic mutations that drive biological processes ultimately reflected in tumor phenotype. With regard to radiographic phenotypes, generally unconnected through present understanding to the presence of specific mutations, artificial intelligence methods can automatically quantify phenotypic characters by using predefined, engineered algorithms or automatic deep-learning methods, a process also known as radiomics. Here we demonstrate how imaging phenotypes can be connected to somatic mutations through an integrated analysis of independent datasets of 763 lung adenocarcinoma patients with somatic mutation testing and engineered CT image analytics. We developed radiomic signatures capable of distinguishing between tumor genotypes in a discovery cohort (n = 353) and verified them in an independent validation cohort (n = 352). All radiomic signatures significantly outperformed conventional radiographic predictors (tumor volume and maximum diameter). We found a radiomic signature related to radiographic heterogeneity that successfully discriminated between EGFR+ and EGFR- cases (AUC = 0.69). Combining this signature with a clinical model of EGFR status (AUC = 0.70) significantly improved prediction accuracy (AUC = 0.75). The highest performing signature was capable of distinguishing between EGFR+ and KRAS+ tumors (AUC = 0.80) and, when combined with a clinical model (AUC = 0.81), substantially improved its performance (AUC = 0.86). A KRAS+/KRAS- radiomic signature also showed significant albeit lower performance (AUC = 0.63) and did not improve the accuracy of a clinical predictor of KRAS status. Our results argue that somatic mutations drive distinct radiographic phenotypes that can be predicted by radiomics. This work has implications for the use of imaging-based biomarkers in the clinic, as applied noninvasively, repeatedly, and at low cost. Cancer Res; 77(14); 3922-30. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28566328      PMCID: PMC5528160          DOI: 10.1158/0008-5472.CAN-17-0122

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  survcomp: an R/Bioconductor package for performance assessment and comparison of survival models.

Authors:  Markus S Schröder; Aedín C Culhane; John Quackenbush; Benjamin Haibe-Kains
Journal:  Bioinformatics       Date:  2011-09-07       Impact factor: 6.937

2.  Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.

Authors:  Ying Liu; Jongphil Kim; Yoganand Balagurunathan; Qian Li; Alberto L Garcia; Olya Stringfield; Zhaoxiang Ye; Robert J Gillies
Journal:  Clin Lung Cancer       Date:  2016-02-16       Impact factor: 4.785

Review 3.  Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology.

Authors:  Pasi A Jänne; Jeffrey A Engelman; Bruce E Johnson
Journal:  J Clin Oncol       Date:  2005-05-10       Impact factor: 44.544

4.  Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC.

Authors:  Raymond H Mak; Hugo J W L Aerts; Thibaud P Coroller; Vishesh Agrawal; Elizabeth Huynh; Vivek Narayan; Stephanie W Lee
Journal:  J Thorac Oncol       Date:  2016-11-27       Impact factor: 15.609

5.  Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer.

Authors:  Viswam S Nair; Olivier Gevaert; Guido Davidzon; Sandy Napel; Edward E Graves; Chuong D Hoang; Joseph B Shrager; Andrew Quon; Daniel L Rubin; Sylvia K Plevritis
Journal:  Cancer Res       Date:  2012-06-18       Impact factor: 12.701

Review 6.  Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.

Authors:  Tianhong Li; Hsing-Jien Kung; Philip C Mack; David R Gandara
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

7.  Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.

Authors:  Stephen S F Yip; John Kim; Thibaud P Coroller; Chintan Parmar; Emmanuel Rios Velazquez; Elizabeth Huynh; Raymond H Mak; Hugo J W L Aerts
Journal:  J Nucl Med       Date:  2016-09-29       Impact factor: 10.057

Review 8.  Applications and limitations of radiomics.

Authors:  Stephen S F Yip; Hugo J W L Aerts
Journal:  Phys Med Biol       Date:  2016-06-08       Impact factor: 3.609

Review 9.  Intratumor heterogeneity: evolution through space and time.

Authors:  Charles Swanton
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  118 in total

1.  Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.

Authors:  Xinguan Yang; Xiao Dong; Jiao Wang; Weiwei Li; Zhuoran Gu; Dashan Gao; Nanshan Zhong; Yubao Guan
Journal:  Oncologist       Date:  2019-04-01

2.  Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement.

Authors:  Ji Eun Park; Donghyun Kim; Ho Sung Kim; Seo Young Park; Jung Youn Kim; Se Jin Cho; Jae Ho Shin; Jeong Hoon Kim
Journal:  Eur Radiol       Date:  2019-07-26       Impact factor: 5.315

3.  Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma.

Authors:  Xianzheng Tan; Zelan Ma; Lifen Yan; Weitao Ye; Zaiyi Liu; Changhong Liang
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

4.  Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas.

Authors:  Shuang Wu; Jin Meng; Qi Yu; Ping Li; Shen Fu
Journal:  J Cancer Res Clin Oncol       Date:  2019-02-04       Impact factor: 4.553

5.  Metabolic Imaging Phenotype Using Radiomics of [18F]FDG PET/CT Associated with Genetic Alterations of Colorectal Cancer.

Authors:  Shang-Wen Chen; Wei-Chih Shen; William Tzu-Liang Chen; Te-Chun Hsieh; Kuo-Yang Yen; Jan-Gowth Chang; Chia-Hung Kao
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

6.  Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features.

Authors:  Ruichuan Shi; Weixing Chen; Bowen Yang; Jinglei Qu; Yu Cheng; Zhitu Zhu; Yu Gao; Qian Wang; Yunpeng Liu; Zhi Li; Xiujuan Qu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 7.  Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues.

Authors:  Aleksandra Karolak; Dmitry A Markov; Lisa J McCawley; Katarzyna A Rejniak
Journal:  J R Soc Interface       Date:  2018-01       Impact factor: 4.118

Review 8.  [Radiomics-AI-based image analysis].

Authors:  A Demircioğlu
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

9.  Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.

Authors:  François Lucia; Dimitris Visvikis; Marie-Charlotte Desseroit; Omar Miranda; Jean-Pierre Malhaire; Philippe Robin; Olivier Pradier; Mathieu Hatt; Ulrike Schick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-09       Impact factor: 9.236

10.  Repeatability of FDG PET/CT metrics assessed in free breathing and deep inspiration breath hold in lung cancer patients.

Authors:  Lotte Nygård; Marianne C Aznar; Barbara M Fischer; Gitte F Persson; Charlotte B Christensen; Flemming L Andersen; Mirjana Josipovic; Seppo W Langer; Andreas Kjær; Ivan R Vogelius; Søren M Bentzen
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.